GenSight Biologics

About:

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Website: https://www.gensight-biologics.com/

Twitter/X: gensightbio

Top Investors: European Investment Bank, Bpifrance, Fidelity, Invus, Perceptive Advisors

Description:

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases. GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy-based treatments of retinal degenerative diseases. Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from very low vision or blindness.